2月25日 - ** 远程医疗公司Hims & Hers HIMS.N股价盘前下跌19.22%，至41.45美元
** 该公司称，在美国食品和药物管理局将诺和诺德公司NOVOb.CO的减肥药Wegovy从短缺药品名单中删除后， (link)，可能无法再销售该药的复方制剂。 (link)
** 添加 (link) 此举可能导致客户取消订购，影响收入
** 股价在过去 12 个月中上涨了 5 倍
(为便利非英文母语者，路透将其报导自动化翻译为数种其他语言。由于自动化翻译可能有误，或未能包含所需语境，路透不保证自动化翻译文本的准确性，仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。)
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.